Retractable Technologies Inc revenue
Retractable Technologies Inc's revenue was $38.3m in fiscal 2025, up 15.8% on the year before. Since fiscal 2009 ($39.0m) it has grown at a compound -0.1% a year. Over the last twelve months it was $33.9m.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39 | 36 | 32 | 34 | 31 | 35 | 30 | 30 | 34 | 33 | 42 | 82 | 188 | 95 | 44 | 33 | 38 | 34 |
| Growth on the year before | — | −7.1% | −11.4% | +4.8% | −8.5% | +12.1% | −14.4% | +0.9% | +15.6% | −3.5% | +25.6% | +95.9% | +130.1% | −49.7% | −54.0% | −24.2% | +15.8% | — |
| Gross profit | 14 | 13 | 11 | 11 | 10 | 12 | 11 | 10 | 10 | 10 | 14 | 37 | 95 | 28 | 9 | −1 | 0 | −0 |
| Gross margin | 34.7% | 34.6% | 34.0% | 33.2% | 33.5% | 34.8% | 35.8% | 34.7% | 28.9% | 30.7% | 33.8% | 45.2% | 50.6% | 29.8% | 20.9% | −3.1% | 0.1% | −1.4% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Syringes | $24.9M | 65.1% | ▲ 10.1% |
| Easy Point Needles | $11.9M | 31.2% | ▲ 33.5% |
| Blood Collection Products | $1.4M | 3.6% | ▼ 3.9% |
| Other Products | $43,627 | 0.1% | ▼ 4.9% |
From Retractable Technologies Inc's 10-K filed March 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Retractable Technologies Inc | $33.9m | -11.2% | -14.7% |
| Orchestra Biomed Holdings, Inc. | $32.0m | 986.1% | 94.5% |
| Utah Medical Products Inc | $36.1m | -7.0% | -11.4% |
| Precision Optics Corporation, Inc. | $31.5m | 65.2% | 14.4% |
| Electrocore, Inc. | $37.0m | 33.5% | 50.4% |
| Cytosorbents Corp | $37.2m | 3.1% | 0.8% |
Compare with peers
- Orchestra Biomed Holdings, Inc. revenue
- Utah Medical Products Inc revenue
- Precision Optics Corporation, Inc. revenue
- Electrocore, Inc. revenue
- Cytosorbents Corp revenue
Head to head: OBIO vs RVPRVP vs UTMDPOCI vs RVPECOR vs RVP
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies